Stay updated on Sabatolimab & Magrolimab Treatment in AML Clinical Trial
Sign up to get notified when there's something new on the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page.

Latest updates to the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRecord History shows a new revision entry: v3.3.2, replacing the previous v3.3.1. This is a minor metadata update to the page history.SummaryDifference0.1%

- Check21 days agoChange DetectedA new revision entry v3.3.1 was added to the record history and the previous v3.2.0 entry was removed.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoved the government funding/operating status banner that warned about potential data delays. The page now presents the study record history without that operational-status message.SummaryDifference0.8%

- Check43 days agoChange DetectedThe two screenshots show the same version history entries with no new data; only minor layout differences are visible, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference13%

- Check79 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Sabatolimab & Magrolimab Treatment in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page.